188 related articles for article (PubMed ID: 26559157)
1. How reader perception of capsule affects interpretation of washout in hypervascular liver nodules in patients at risk for hepatocellular carcinoma.
Sofue K; Sirlin CB; Allen BC; Nelson RC; Berg CL; Bashir MR
J Magn Reson Imaging; 2016 Jun; 43(6):1337-45. PubMed ID: 26559157
[TBL] [Abstract][Full Text] [Related]
2. Concordance of hypervascular liver nodule characterization between the organ procurement and transplant network and liver imaging reporting and data system classifications.
Bashir MR; Huang R; Mayes N; Marin D; Berg CL; Nelson RC; Jaffe TA
J Magn Reson Imaging; 2015 Aug; 42(2):305-14. PubMed ID: 25371354
[TBL] [Abstract][Full Text] [Related]
3. Rate of observation and inter-observer agreement for LI-RADS major features at CT and MRI in 184 pathology proven hepatocellular carcinomas.
Ehman EC; Behr SC; Umetsu SE; Fidelman N; Yeh BM; Ferrell LD; Hope TA
Abdom Radiol (NY); 2016 May; 41(5):963-9. PubMed ID: 27193793
[TBL] [Abstract][Full Text] [Related]
4. Reliability, Validity, and Reader Acceptance of LI-RADS-An In-depth Analysis.
Barth BK; Donati OF; Fischer MA; Ulbrich EJ; Karlo CA; Becker A; Seifert B; Reiner CS
Acad Radiol; 2016 Sep; 23(9):1145-53. PubMed ID: 27174029
[TBL] [Abstract][Full Text] [Related]
5. Imaging features of hepatocellular carcinoma compared to intrahepatic cholangiocarcinoma and combined tumor on MRI using liver imaging and data system (LI-RADS) version 2014.
Horvat N; Nikolovski I; Long N; Gerst S; Zheng J; Pak LM; Simpson A; Zheng J; Capanu M; Jarnagin WR; Mannelli L; Do RKG
Abdom Radiol (NY); 2018 Jan; 43(1):169-178. PubMed ID: 28765978
[TBL] [Abstract][Full Text] [Related]
6. Interobserver and intermodality agreement of standardized algorithms for non-invasive diagnosis of hepatocellular carcinoma in high-risk patients: CEUS-LI-RADS versus MRI-LI-RADS.
Schellhaas B; Hammon M; Strobel D; Pfeifer L; Kielisch C; Goertz RS; Cavallaro A; Janka R; Neurath MF; Uder M; Seuss H
Eur Radiol; 2018 Oct; 28(10):4254-4264. PubMed ID: 29675659
[TBL] [Abstract][Full Text] [Related]
7. Liver imaging reporting and data system v2014 categorization of hepatocellular carcinoma on gadoxetic acid-enhanced MRI: Comparison with multiphasic multidetector computed tomography.
Joo I; Lee JM; Lee DH; Ahn SJ; Lee ES; Han JK
J Magn Reson Imaging; 2017 Mar; 45(3):731-740. PubMed ID: 27474328
[TBL] [Abstract][Full Text] [Related]
8. Liver Imaging Reporting and Data System:: Substantial Discordance Between CT and MR for Imaging Classification of Hepatic Nodules.
Zhang YD; Zhu FP; Xu X; Wang Q; Wu CJ; Liu XS; Shi HB
Acad Radiol; 2016 Mar; 23(3):344-52. PubMed ID: 26777590
[TBL] [Abstract][Full Text] [Related]
9. Liver Imaging Reporting and Data System: Discordance Between Computed Tomography and Gadoxetate-Enhanced Magnetic Resonance Imaging for Detection of Hepatocellular Carcinoma Major Features.
Chernyak V; Flusberg M; Law A; Kobi M; Paroder V; Rozenblit AM
J Comput Assist Tomogr; 2018; 42(1):155-161. PubMed ID: 28806321
[TBL] [Abstract][Full Text] [Related]
10. Repeatability of diagnostic features and scoring systems for hepatocellular carcinoma by using MR imaging.
Davenport MS; Khalatbari S; Liu PS; Maturen KE; Kaza RK; Wasnik AP; Al-Hawary MM; Glazer DI; Stein EB; Patel J; Somashekar DK; Viglianti BL; Hussain HK
Radiology; 2014 Jul; 272(1):132-42. PubMed ID: 24555636
[TBL] [Abstract][Full Text] [Related]
11. Computer-aided diagnosis program for classifying the risk of hepatocellular carcinoma on MR images following liver imaging reporting and data system (LI-RADS).
Kim Y; Furlan A; Borhani AA; Bae KT
J Magn Reson Imaging; 2018 Mar; 47(3):710-722. PubMed ID: 28556283
[TBL] [Abstract][Full Text] [Related]
12. Reliability of extracellular contrast versus gadoxetic acid in assessing small liver lesions using liver imaging reporting and data system v.2018 and European association for the study of the liver criteria.
Rimola J; Sapena V; Brancatelli G; Darnell A; Forzenigo L; Mähringer-Kunz A; Paisant A; Renzulli M; Schima W; Terraz S; Valls C; Wagner M; Ayuso C; Vilgrain V; Reig M; Ronot M
Hepatology; 2022 Nov; 76(5):1318-1328. PubMed ID: 35349760
[TBL] [Abstract][Full Text] [Related]
13. Imaging features of subcentimeter hypointense nodules on gadoxetic acid-enhanced hepatobiliary phase MR imaging that progress to hypervascular hepatocellular carcinoma in patients with chronic liver disease.
Jang KM; Kim SH; Kim YK; Choi D
Acta Radiol; 2015 May; 56(5):526-35. PubMed ID: 24838304
[TBL] [Abstract][Full Text] [Related]
14. An overview of hepatocellular carcinoma with atypical enhancement pattern: spectrum of magnetic resonance imaging findings with pathologic correlation.
Kovac JD; Ivanovic A; Milovanovic T; Micev M; Alessandrino F; Gore RM
Radiol Oncol; 2021 Jan; 55(2):130-143. PubMed ID: 33544992
[TBL] [Abstract][Full Text] [Related]
15. High-flow haemangiomas versus hypervascular hepatocellular carcinoma showing "pseudo-washout" on gadoxetic acid-enhanced hepatic MRI: value of diffusion-weighted imaging in the differential diagnosis of small lesions.
Nam SJ; Yu JS; Cho ES; Kim JH; Chung JJ
Clin Radiol; 2017 Mar; 72(3):247-254. PubMed ID: 27789027
[TBL] [Abstract][Full Text] [Related]
16. Intrahepatic distant recurrence after radiofrequency ablation for hepatocellular carcinoma: precursor nodules on pre-procedural gadoxetic acid-enhanced liver magnetic resonance imaging.
Song KD; Rhim H; Lee MW; Kim YS; Kang TW
Acta Radiol; 2017 Jul; 58(7):778-785. PubMed ID: 27903759
[TBL] [Abstract][Full Text] [Related]
17. Retrospective analysis of current guidelines for hepatocellular carcinoma diagnosis on gadoxetic acid-enhanced MRI in at-risk patients.
Park SH; Shim YS; Kim B; Kim SY; Kim YS; Huh J; Park JH; Kim KW; Lee SS
Eur Radiol; 2021 Jul; 31(7):4751-4763. PubMed ID: 33389037
[TBL] [Abstract][Full Text] [Related]
18. Presence of a hypovascular hepatic nodule showing hypointensity on hepatocyte-phase image is a risk factor for hypervascular hepatocellular carcinoma.
Ichikawa S; Ichikawa T; Motosugi U; Sano K; Morisaka H; Enomoto N; Matsuda M; Fujii H; Araki T
J Magn Reson Imaging; 2014 Feb; 39(2):293-7. PubMed ID: 23633285
[TBL] [Abstract][Full Text] [Related]
19. Non-alcoholic fatty liver disease-associated hepatocellular carcinoma: effect of hepatic steatosis on major hepatocellular carcinoma features at MRI.
Thompson SM; Garg I; Ehman EC; Sheedy SP; Bookwalter CA; Carter RE; Roberts LR; Venkatesh SK
Br J Radiol; 2018 Dec; 91(1092):20180345. PubMed ID: 30074820
[TBL] [Abstract][Full Text] [Related]
20. Radiomics machine-learning signature for diagnosis of hepatocellular carcinoma in cirrhotic patients with indeterminate liver nodules.
Mokrane FZ; Lu L; Vavasseur A; Otal P; Peron JM; Luk L; Yang H; Ammari S; Saenger Y; Rousseau H; Zhao B; Schwartz LH; Dercle L
Eur Radiol; 2020 Jan; 30(1):558-570. PubMed ID: 31444598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
